期刊文献+

LC-MS-MS法测定犬体内血浆中埃索美拉唑药物浓度 被引量:3

Determination of Esomeprazole in dog plasma by LC-MS-MS
暂未订购
导出
摘要 目的建立液相色谱联用质谱法(LC-MS-MS)测定犬体内血浆中埃索美拉唑(esomeprazole,EMZ)药物浓度。方法以地西泮为内标,血浆采用蛋白沉淀处理,色谱柱为Shim-pack XR-ODS柱(2 mm×100 mm,5μm);流动相为乙腈:2mmol/L乙酸铵(含0.1%甲酸);流速0.3 ml/min;质谱条件:电喷雾离子化电离源ESI,正离子多反应检测,检测离子分别为346.2→198.2 m/z(埃索美拉唑)和285.2→193.2 m/z(地西泮)。结果埃索美拉唑在0.5~1 200μg/L检测浓度范围内呈良好线性关系(r>0.99),最低定量限(LLOQ)为0.5μg/L,平均绝对回收率在(101.0±6.5)%,低、中、高3种浓度的日内、日间RSD≤15%。结论该方法操作简便、灵敏、准确,适用于埃索美拉唑血药浓度测定及药动学研究。 Objective To establish a method for determining Esomeprazole in dog plasma by LC-MS-MS. Methods Diaze- pam was used as the internal standard ,the samples were precipitated with acetonitril. Analytical column was Shim-pack XR-ODS (2 mm × 100 mm, 5 μm). The mobile phase was acetonitrile:2 mmol/L ammonium acetate( containing 0.1% formic acid) at a flow rate of 0.3 ml/min. Mass spectrum conditions was ESI performing in positive ion MRM mode using target ions 346.2-198.2 m/z( esome- prazole) and 285.2-193.2 m/z(diazepam). Results The calibration curve was linear over the range of 0.5 - 1 200μg/L . The LLOQ of Esomeprazole in plasma was 0.5 μg/L . The average extracted recovery was( 101.0 ± 6.5) %. The RSDs of intra- and inter- day were less than 15%. Conclusion The method was sensitive, simple and accurate to determinate Esomeprazole plasma concentra- tion and suitable to the pharmacokinetics study.
出处 《药学实践杂志》 CAS 2013年第1期61-63,共3页 Journal of Pharmaceutical Practice
关键词 埃索美拉唑 液相色谱联用质谱 血药浓度 Esomeprazole LC-MS-MS plasma concentration
  • 相关文献

参考文献3

二级参考文献17

  • 1楼雅卿,赵莉,张远.中国健康志愿者的奥美拉唑及其代谢物的药代动力学研究[J].中国临床药理学杂志,1994,10(1):14-21. 被引量:27
  • 2Ia Huhman, Helene Stenhoff, Mathias Liljeblad. Determination of es- omeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry[ JJ. Journal of Chromatography B, 2007,848:317- 322.
  • 3Scott LJ,Dunn ChJ,Mallarkey G,et al.Esomeprazole:a review of its use in the management of acid-related disorders in the US[J].Drugs,2002,62(7):1091-1118.
  • 4Scott LJ,Dunn ChJ,Mallarkey G,et al.Esomeprazole:a review of its use in the management of acid-related disorders in the US[J].Drugs,2002,62(10):1503-1538.
  • 5Andersson T,Bredberg E,Sunzel M,et al.Pharmacokinetics and effect on pentagastrin stimulated peak acid output (PAO) of omeprazole and its 2 optical isomers,S-omeprazole / esomeprazole and R-omeprazole[J].Gastroenterology,2000,118∶A1210.
  • 6Abelo A,Andersson TB,Antonsson M,et al.Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes[J].Drug Metab Dispos,2000,28(8):966-972.
  • 7Kanazawa H,Okada A,Higake M,et al.Stereospecific analysis of omeprazole in human plasma as a probe for CYP2C19 phenotype[J].J Pharm Biomed Anal,2003,30(6):1817-1827.
  • 8Andersson T.Omeprazole drug interaction studies[J].Clin Pharm,1991,21(3):195-212.
  • 9Phenotype of CyP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid-liquid extraction[J].Journal of Chromtography B,2002,780:459-465.
  • 10田冀媛.HPLC-MS法测定人血浆奥美拉唑的水平[J].南华大学学报(医学版),2008,36(3):354-357. 被引量:4

共引文献61

同被引文献33

  • 1余勤,梁茂植,赵焱,秦永平,邹远高,南峰,黄帮华.反相高效液相色谱法测定血浆中埃索美拉唑浓度[J].华西医学,2006,21(1):93-95. 被引量:6
  • 2孙传兴.临床疾病诊断依据治愈好转标准[M]第2版[M].北京:人民军医出版社,1998.41-182.
  • 3陈灏珠,林果为.实用内科学[M].第13版.北京:人民卫生出版社,2009:807-809.
  • 4Barkun AN, Bardou M, Kuipers E J, et al.International Consensus Upper Gastrointestinal Bleeding Conference Group. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding[J].Ann Intern Med, 2010, 152 (2): 101-113.
  • 5黄兆许,蒋元武.奥曲肽、埃索美拉唑联合法对上消化道大出血患者的疗效观察[J].医学信息,2013,26(5):626-627.
  • 6Wilder-Smith C, Backlund A, Eekerwall G, et al.Effect of increasing esomeprazole and pantoprasole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study[J]. Clin Drug Inveaig,2008,28 ( 6 ) : 333-343.
  • 7Barkun AN, Adam V, Sung JJ, et al.Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding[J].Pharmacoeconnmics, 2010,28 ( 3 ): 217-230.
  • 8陈刚.2种埃索美拉唑制剂的人体生物等效性研究[J].中国药房,2009,20(2):116-118. 被引量:11
  • 9张晖敏,缪应雷.埃索美拉唑的临床应用新进展[J].世界华人消化杂志,2009,17(20):2064-2069. 被引量:59
  • 10无.急性非静脉曲张性上消化道出血诊治指南(2009,杭州)[J].中华消化内镜杂志,2009(9):449-452. 被引量:161

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部